Trulicity is a brand-name, injectable dulaglutide medication approved by the U.S. Food and Drug Administration (FDA) to treat ...
@2024 - All Right Reserved.
New indication reflects distinct patient population in the REWIND study, including primarily people with multiple cardiovascular risk factors but without established cardiovascular disease ...
AWARD-11 showed 3.0 mg and 4.5 mg doses led to additional blood sugar control; as a secondary endpoint, both doses also led to weight loss INDIANAPOLIS, Sept. 3, 2020 /PRNewswire/ -- The U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results